Mimotopes Pty Ltd, established in Melbourne, Australia in 1988, is recognized as oneof thefirstcombinatorial chemistry companies formed and an industry leader in the peptideand discovery chemistry sector. The pioneering work of Dr. Mario Geysen enabled the parallelsynthesisof peptides and subsequently small molecules to become mainstream. Mimotopesdevelops, markets and distributes sophisticated biochemical productsand services for the biotech and pharmaceutical industries. Mimotopes uses proprietarytechnologies in solid phase synthesis, molecule scavenging applicationsand biomolecularcapture and immobilisation. Mimotopes' expertise in polymer chemistry has enabled it tolaunched the mostr espected and advanced solid phase synthesis platforms for solid phasesynthesis of drug-like molecules(SynPhaseTMLanterns). Mimotopes is the preeminentepitope mapping company covering all forms of B-andT-cell epitope mapping for drugdiscovery and vaccine research making important contributions in developing diagnosticsand vaccine candidates.